209 related articles for article (PubMed ID: 16447725)
1. [Development of personalized peptide vaccines for advanced cancer patients].
Yamada A
Rinsho Ketsueki; 2005 Jun; 46(6):433-8. PubMed ID: 16447725
[No Abstract] [Full Text] [Related]
2. [Peptide-based vaccine therapy for cancer patients].
Yamada A
Nihon Rinsho; 2005 Apr; 63 Suppl 4():602-7. PubMed ID: 15861717
[No Abstract] [Full Text] [Related]
3. [New era of tumor immunotherapy].
Yoshitake Y; Nakatsura T; Nishimura Y
Nihon Rinsho; 2005 Apr; 63 Suppl 4():46-55. PubMed ID: 15861634
[No Abstract] [Full Text] [Related]
4. Challenges for cancer vaccine development.
Tabi Z; Man S
Adv Drug Deliv Rev; 2006 Oct; 58(8):902-15. PubMed ID: 16979786
[TBL] [Abstract][Full Text] [Related]
5. Cancer vaccines for established cancer: how to make them better?
Andrews DM; Maraskovsky E; Smyth MJ
Immunol Rev; 2008 Apr; 222():242-55. PubMed ID: 18364006
[TBL] [Abstract][Full Text] [Related]
6. Multipeptide vaccination in cancer patients.
Pilla L; Rivoltini L; Patuzzo R; Marrari A; Valdagni R; Parmiani G
Expert Opin Biol Ther; 2009 Aug; 9(8):1043-55. PubMed ID: 19591629
[TBL] [Abstract][Full Text] [Related]
7. International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain.
Aptsiauri N; Cabrera T; Pawelec G; Gouttefangeas C; Derhovanessian E; Garrido F; Garcia-Lora A
Cancer Immunol Immunother; 2007 Aug; 56(8):1311-22. PubMed ID: 17375297
[No Abstract] [Full Text] [Related]
8. Immunotherapeutic peptide vaccination with leukemia-associated antigens.
Rusakiewicz S; Molldrem JJ
Curr Opin Immunol; 2006 Oct; 18(5):599-604. PubMed ID: 16870418
[TBL] [Abstract][Full Text] [Related]
9. Immunological evaluation of neoadjuvant peptide vaccination before radical prostatectomy for patients with localized prostate cancer.
Noguchi M; Yao A; Harada M; Nakashima O; Komohara Y; Yamada S; Itoh K; Matsuoka K
Prostate; 2007 Jun; 67(9):933-42. PubMed ID: 17440952
[TBL] [Abstract][Full Text] [Related]
10. Vaccines: an innovative approach to treating cancer.
Pazdur MP; Jones JL
J Infus Nurs; 2007; 30(3):173-8. PubMed ID: 17505219
[TBL] [Abstract][Full Text] [Related]
11. Advances in the development of a therapeutic cancer vaccine.
Avigan D
J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S2-6. PubMed ID: 16280106
[No Abstract] [Full Text] [Related]
12. Tumor antigens as surrogate markers and targets for therapy and vaccines.
Dalgleish A; Pandha H
Adv Cancer Res; 2007; 96():175-90. PubMed ID: 17161680
[TBL] [Abstract][Full Text] [Related]
13. [Peptide vaccination therapy for malignant glioma].
Yamanaka R; Itoh K
Brain Nerve; 2007 Mar; 59(3):251-61. PubMed ID: 17370651
[TBL] [Abstract][Full Text] [Related]
14. Update on vaccines for solid tumors.
Gajewski TF
Clin Adv Hematol Oncol; 2004 Mar; 2(3):158-9. PubMed ID: 16166944
[No Abstract] [Full Text] [Related]
15. Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine.
Noguchi M; Sasada T; Itoh K
Cancer Immunol Immunother; 2013 May; 62(5):919-29. PubMed ID: 23197273
[TBL] [Abstract][Full Text] [Related]
16. Immunity to melanoma antigens: from self-tolerance to immunotherapy.
Slingluff CL; Chianese-Bullock KA; Bullock TN; Grosh WW; Mullins DW; Nichols L; Olson W; Petroni G; Smolkin M; Engelhard VH
Adv Immunol; 2006; 90():243-95. PubMed ID: 16730266
[TBL] [Abstract][Full Text] [Related]
17. Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients.
Bins A; Mallo H; Sein J; van den Bogaard C; Nooijen W; Vyth-Dreese F; Nuijen B; de Gast GC; Haanen JB
J Immunother; 2007; 30(2):234-9. PubMed ID: 17471170
[TBL] [Abstract][Full Text] [Related]
18. [Current status and future perspective of peptide vaccine for biliary tract cancer].
Aruga A
Nihon Rinsho; 2015 Mar; 73 Suppl 3():823-6. PubMed ID: 25857143
[No Abstract] [Full Text] [Related]
19. A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer.
Chianese-Bullock KA; Irvin WP; Petroni GR; Murphy C; Smolkin M; Olson WC; Coleman E; Boerner SA; Nail CJ; Neese PY; Yuan A; Hogan KT; Slingluff CL
J Immunother; 2008 May; 31(4):420-30. PubMed ID: 18391753
[TBL] [Abstract][Full Text] [Related]
20. Immunology and breast cancer: therapeutic cancer vaccines.
Curigliano G; Rescigno M; Goldhirsch A
Breast; 2007 Dec; 16 Suppl 2():S20-6. PubMed ID: 17706425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]